Adam Cox is joined by Dr Juho Jalkanen, the CEO of Faron Pharmaceuticals. They discuss a groundbreaking development for cancer treatment, a promising new drug is set to enter late-stage clinical trials here in the UK. Bexmarilimab offers hope to the millions of people suffering from various deadly forms of blood cancer and leukaemia worldwide – where current treatment options are largely failing.